Abstract
The review addresses the role of Ca2+ ions in the development of ischemic disorders of myocardial contractility associated with changes in Ca2+ homeostasis in cardiomyocytes and mitochondrial Ca2+ overload. A special attention is paid to the analysis of intracellular signaling mechanisms activated during the development of ischemic and reperfusion injury of the myocardium.
Similar content being viewed by others
References
Goldenthal, M.J., Mitochondrial involvement in myocyte death and heart failure, Heart Fail. Rev., 2016, vol. 21, pp. 137–155.
Mironkov, A.B., Myocardial revascularization in treatment of patients with systemic left ventricular dysfunction: the state of the problem, Vestn. Transplant. Iskusstv. Organs, 2013, vol. 15, no. 2, pp. 156–163.
Coetzee, W.A., Multiplicity of effectors of the cardioprotective agent, diazoxide, Pharmacol. Ther., 2013, vol. 140, pp. 167–175.
Henn, M.C., Janjua, M.B., Kanter, E.M., Makepeace, C.M., Schuessler, R.B., Nichols, C.G., and Lawton, J.S., Adenosine triphosphate-sensitive potassium channel Kir subunits implicated in cardioprotection by diazoxide, J. Amer. Heart Assoc., 2015, vol. 4, p. e002016.
Korotkov, S.M., Emelyanova, L.V., Brailovskaya, I.V., and Nesterov, V.P., The effect of pinacidil and calcium on isolated rat heart mitochondria, Dokl. Akad. Nauk, 2012, vol. 443, no. 5, pp. 632–636.
Kholmukhamedov, E.L., The role of mitochondria in providing normal vital activity and survival of mammalian cells, Doctorate Sci. Diss., Pushchino, 2009.
Neiler, V.G. and Deily, M.J., Calcium and cardiomyocyte damages, Fiziologiya i patofiziologiya serdtsa (Physiology and Pathophysiology of the Heart), Sperelakis, N., Ed., Moscow, 1990, vol. 1, pp. 556–578.
Onukwufor, J.O., Stevens, D., and Kamunde, C., Bioenergetic and volume regulatory effects of mitoKATP channel modulators protect against hypoxia–reoxygenation-induced mitochondrial dysfunction, J. Exp. Biol., 2016. doi: 10.1242/jeb.140186
Laskowski, M., Augustynek, B., Kulawiak, B., Koprowski, P., Bednarczyk, P., Jarmuszkiewicz, W., and Szewczyk, A., What do we not know about mitochondrial potassium channels? Biochem. Biophys. Acta, 2016, vol. 1857, pp. 1247–1257.
Pogorelov, A.G., Electron probe studies of the elemental (K, Na, Cl) balance in myocardial cells under early ischemia, Doctorate Sci. Diss., Pushchino, 2000.
Chernov, Yu.N., Vasin, M.V., and Batishcheva, G.A., Pathological changes in cell membranes under ischemic heart disease and possible ways of its pharmacological correction, Eksper. Klin. Farmakol., 1994, no. 4, pp. 67–72.
Veksler, V.I., Elizarova, E.P., and Kapelko, V.I., The effect of phosphate and acidosis on calcium sensitivity of myofibrils, Byul. Eksper. Biol. Med., 1985, no. 2, pp. 133–135.
Alabovskiy, V.V., Vinokurov, A.A., Basharina, O.V., Maslov, O.V., Khamburov, V.V., Zolotukhina, V.I., and Popova, L.I., Dependence of Na+–Ca2+ exchange rate on extracellular sodium and potassium concentrations in isolated rat heart, Vestn. Novykh Med. Tekhnol., 2011, vol. 18, no. 2, pp. 2–14.
Clanachan, A.S., Contribution of protons to postischemic Na+ and Ca2+ overload and left ventricular mechanical dysfunction, J. Cardiovasc. Electrophysiol., 2006, suppl. 1, pp. S141–S148.
Wei, A.C., Liu, T., Cortassa, S., Winslow, R.L., and O’Rourke, B., Mitochondrial Ca2+ influx and efflux rates in guinea pig cardiac mitochondria: low and high affinity effects of cyclosporine A, Biochim. Biophys. Acta, 2011, vol. 1813, pp. 1373–1381.
Zheng, D., Wang, G., Li, S., Fan, G.C., and Peng, T., Calpain-1 induces endoplasmic reticulum stress in promoting cardiomyocyte apoptosis following hypoxia/reoxygenation, Biochim. Biophys. Acta, 2015, vol. 1852, pp. 882–892.
Chen, F.F., Vaughan-Jones, R.D., Clarke, K., and Noble, D., Modelling myocardial ischaemia and reperfusion, Prog. Biophys. Mol. Biol., 1998, vol. 69, pp. 515–538.
Lehnart, S.E., Maier, L.S., and Hasenfuss, G., Abnormalities of calcium metabolism and myocardial contractility depression in the failing heart, Heart Fail. Rev., 2009, vol. 14, pp. 213–224.
Yano, M., Yamamoto, T., Kobayashi, S., Ikeda, Y., and Matsuzaki, M., Defective Ca2+ cycling as a key pathogenic mechanism of heart failure, Circ. J., 2008, vol. 72, suppl. A, pp. A22–А30.
Bockeria, L.A. and Chicherin, I.N., Priroda i klinicheskoe znachenie “novykh ishemicheskikh sindromov” (Nature and Clinical Significance of the “Novel Ischemic Syndromes”), Moscow, 2007.
Grishina, E.V., Khaustov, Ya.V., and Maevsky, E.I., Inhibition of Ca-induced calcium release from mitochondria by anti-ischemic phenol antioxidants, Biol. Membr., 2009, vol. 26, no. 6, pp. 505–513.
Sommer, S., Leistner, M., Aleksic, I., Schimmer, C., Alhussini, K., Kanofsky, P., Leyh, R.G., and Sommer, S.P., Impact of levosimendan and ischaemia-reperfusion injury on myocardial subsarcolemmal mitochondrial respiratory chain, mitochondrial membrane potential, Ca2+ cycling and ATP synthesis, Eur. J. Cardiothorac. Surg., 2016, vol. 49, pp. e54–e62.
Willis, B.C., Salazar-Cantú, A., Silva-Platas, C., Fernández-Sada, E., Villegas, C.A., Rios-Argaiz, E., González-Serrano, P., Sánchez, L.A., Guerrero-Beltrán, C.E., García, N., Torre-Amione, G., García-Rivas, G.J., and Altamirano, J., Impaired oxidative metabolism and calcium mishandling underlie cardiac dysfunction in a rat model of post-acute isoproterenol-induced cardiomyopathy, Am. J. Physiol. Heart Circ. Physiol., 2015, vol. 308, pp. H467–H477.
Saakyan, I.R., Sherdukalova, L.F., and Saakyan, G.G., Assessment of energy-dependent Ca2+ transport in cardiac muscle mitochondria under ventricular fibrillation: diagnostic capacities of the method, Biomed. Khim., 2003, no. 5, pp. 463–469.
Hunter, D.R. and Haworth, R.A., The Ca2+-induced membrane transition in mitochondria. Transitional Ca2+ release, Arch. Biochem. Biophys., 1979, vol. 195, pp. 468–477.
Haworth, R.A. and Hunter, D.R., The Ca2+-induced membrane transition in mitochondria. Nature of the Ca2+ trigger site, Arch. Biochem. Biophys., 1979, vol. 195, pp. 460–467.
Korotkov, S.M., Sobol, K.V., Shemarova, I.V., Furaev, V.V., and Nesterov, V.P., Comparative study of Y3+ effect on calcium-dependent processes in frog cardiac muscle and mitochondria of rat cardiomyocytes, Zh. Evol. Biokhim. Fiziol., 2016, vol. 52, no. 3, pp. 177–183.
Orlov, Yu.P., Energy deficit in critical conditions: the value of succinates (a review of the problem), Med. Alfavit Neotl. Med., 2013, no. 3, pp. 27–34.
Grin’, V.K., Kalinkina, N.V., Kolesnikov, V.S., and Vatutin, N.T., The preconditioning phenomenon, Ukr. Kardiol. Zh., 2011, no. 6, pp. 79–87.
Kremastinos, D.T., The phenomenon of preconditioning today, Hell. J. Cardiol., 2005, vol. 46, pp. 1–4.
Lange, R., Ingwall, J.S., Hale, S.L., Alker, K.J., and Kloner, R.A., Effects of recurrent ischemia on myocardial high energy phosphate content in canine hearts, Basic Res. Cardiol., 1984, vol. 79, pp. 469–478.
Murry, C.E., Jennings, R.B., and Reimer, K.A., Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium, Circulation, 1986, vol. 74, pp. 1124–1136.
Shizukuda, Y., Mallet, R.T., Lee, S.C., and Downey, H.F., Hypoxic preconditioning of ischaemic canine myocardium, Cardiovasc. Res., 1992, vol. 26, pp. 534–542.
Jennings, R.B., Sebbag, L., Schwartz, L.M., Crago, M.S., and Reimer, K.A., Metabolism of preconditioned myocardium: effect of loss and reinstatement of cardioprotection, J. Mol. Cell Cardiol., 2001, vol. 33, pp. 1571–1588.
Murry, C.E., Richard, V.J., Reimer, K.A., and Jennings, R.B., Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode, Circ. Res., 1990, vol. 66, pp. 913–931.
Likhvantsev, V.V., Skripkin, Yu.V., and Grebenchikov, O.A., Investigation of the clinical value of anesthetic preconditioning (an open access database), Vestn. Anestez. Reanim., 2014, no. 4, pp. 73–75.
Downey, J.M., Davis, A.M., and Cohen, M.V., Signaling pathways in ischemic preconditioning, Heart Fail. Rev., 2007, vol. 12, pp. 181–188.
Likhvantsev, V.V., Moroz, V.V., Grebenchikov, O.A., Grokhovatsky, Yu.I., Zarzhetsky, Yu.V., Timoshin, S.S., Levikov, D.I., and Shaibakova, V.L., Ischemic and pharmacological preconditioning, Obshch. Reanemat., 2011, vol. 7, no. 6, pp. 59–65.
Garlid, K.D., Dos Santos, P., Xie, Z.J., Costa, A.D., and Paucek, P., Mitochondrial potassium transport: the role of the mitochondrial ATPsensitive K+-channel in cardiac function and cardioprotection, Biochim. Biophys. Acta, 2003, vol. 1606, pp. 1–21.
Budas, G., Costa, H.M., Ferreira, J.C., Teixeira da Silva Ferreira, A., Perales, J., Krieger, J.E., Mochly-Rosen, D., and Schechtman, D., Identification of εPKC targets during cardiac ischemic injury, Circ. J., 2012, vol. 76, pp. 1476–1485.
Ping, P., Zhang, J., Zheng, Y.T., Li, R.C., Dawn, B., Tang, X.L., Takano, H., Balafanova, Z., and Bolli, R., Demonstration of selective protein kinase C-dependent activation of Src and Lck tyrosine kinases during ischemic preconditioning in conscious rabbits, Circ. Res., 1999, vol. 85, pp. 542–550.
Ma, L.L., Ge, H.W., Kong, F.J., Qian, L.B., Hu, B.C., Li, Q., Xu, L., Liu, J.Q., Xu, Y.X., and Sun, R.H., Ventricular hypertrophy abrogates intralipid-induced cardioprotection by alteration of reperfusion injury salvage kinase/glycogen synthase kinase 3β signal, Shock, 2014, vol. 41, pp. 435–442.
Juhaszova, M., Zorov, D.B., Kim, S.H., Pepe, S., Fu, Q., Fishbein, K.W., Ziman, B.D., Wang, S., Ytrehus, K., Antos, C.L., Olson, E.N., and Sollott, S.J., Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore, J. Clin. Invest., 2004, vol. 113, pp. 1535–1549.
Zorov, D.B., Juhaszova, M., Yaniv, Y., Nuss, H.B., Wang, S., and Sollott, S.J., Regulation and pharmacology of the mitochondrial permeability transition pore, Cardiovasc. Res., 2009, vol. 83, pp. 213–225.
Kroemer, G., Dallaporta, B., and Resche-Rigon, M., The mitochondrial death/life regulator in apoptosis and necrosis, Ann. Rev. Physiol., 1998, vol. 60, pp. 619–642.
Karch, J. and Molkentin, J.D., Regulated necrotic cell death: the passive aggressive side of Bax and Bak, Circ. Res., 2015, vol. 116, pp. 1800–1809.
Kowaltowski, A.J., Castilho, R.F., and Vercesi, A.E., Mitochondrial permeability transition and oxidative stress, FEBS Lett., 2001, vol. 495, pp. 12–15.
Grachev, D.E., Role of the peripheral benzodiazepine receptor at initial stages of apoptosis and induction of nonspecific mitochondrial pore, Candidate Diss., Pushchino, 2009.
Korotkov, S.M., Konovalova, S.A., Brailovskaya, I.V., and Saris, N.E., To involvement the conformation of the adenine nucleotide translocase in opening the Tl+-induced permeability transition pore in Ca2+-loaded rat liver mitochondria, Toxicol. In Vitro, 2016, vol. 32, pp. 320–332.
Calmettes, G., Ribalet, B., John, S., Korge, P., Ping, P., and Weiss, J.N., Hexokinases and cardioprotection, J. Mol. Cell Cardiol., 2015, vol. 78, pp. 107–115.
Datler, C., Pazarentzos, E., Mahul-Mellier, A.L., Chaisaklert, W., Hwang, M.S., Osborne, F., and Grimm, S., CKMT1 regulates the mitochondrial permeability transition pore in a process that provides evidence for alternative forms of the complex, J. Cell Sci., 2014, vol. 127, pp. 1816–1828.
Halestrap, A.P. and Brenner, C., The adenine nucleotide translocase: a central component of the mitochondrial permeability transition pore and key player in cell death, Curr. Med. Chem., 2003, vol. 10, pp. 1507–1525.
Crompton, M., The mitochondrial permeability transition pore and its role in cell death, Biochem. J., 1999, vol. 341, pp. 233–249.
Baines, C.P., The molecular composition of the mitochondrial permeability transition pore, J. Mol. Cell. Cardiol., 2009, vol. 46, pp. 850–857.
Azarashvili, T., Odinokova, I., Bakunts, A., Ternovsky, V., Krestinina, O., Tyynelä, J., and Saris, N.E., Potential role of subunit c of F0F1- ATPase and subunit c of storage body in the mitochondrial permeability transition. Effect of the phosphorylation status of subunit c on pore opening, Cell Calcium, 2014, vol. 55, pp. 69–77.
Saris, N.E., Potential role of subunit c of F0F1-ATPase and subunit c of storage body in the mitochondrial permeability transition. Effect of the phosphorylation status of subunit c on pore opening, Cell Calcium, 2014, vol. 55, pp. 69–77.
Lebuffe, G., Schumacker, P.T., Shao, Z.H., Anderson, T., Iwase, H., and Van den Hoek, T.L., ROS and NO trigger early preconditioning: relationship to mitochondrial KATP channel, Am. J. Physiol. Heart Circ. Physiol., 2003, vol. 284, pp. H299–H308.
Tang, X.L., Takano, H., Rizvi, A., Turrens, J.F., Qiu, Y., Wu, W.J., Zhang, Q., and Bolli, R., Oxidant species trigger late preconditioning against myocardial stunning in conscious rabbits, Am. J. Physiol. Heart Circ. Physiol., 2002, vol. 282, pp. H281–H291.
Green, D.R. and Reed, J.C., Mitochondria and apoptosis, Science, 1998, vol. 281, pp. 1309–1312.
Borisov, L.Yu., Pharmacological preconditioning of the myocardium in surgery with artificial blood circulation, Candidate Sci. Diss., Moscow, 2013.
Shemarova, I.V. and Nesterov, V.P., Role of Ca2+ and sympathetic neurotransmitters in stress signal transmission in cardiomyocytes, Zh. Evol. Biokhim. Fiziol., 2006, vol. 42, no. 2, pp. 97–104.
Karpova, E.S., Ischemic preconditioning and its cardioprotective effect in rehabilitation programs of patients with ischemic heart disease after transcutaneous coronary interventions, Ross. Kardiol. Zh., 2012, no. 4, pp. 104–108.
Hausenloy, D.J., Ong, S.B., and Yellon, D.M., The mitochondrial permeability transition pore as a target for preconditioning and postconditioning, Basic Res. Cardiol., 2009, vol. 104, pp. 189–202.
Boitsov, S.A., Pathogenesis of chronic ischemic heart disease, Rukovodstvo po aterosklerozu i ishemicheskoi bolezni serdtsa (Handbook of Atherosclerosis and Ischemic Heart Disease, Chazov, E.I., Ed.), Moscow, 2007, pp. 330–348.
Zhang, J.Y., Cheng, K., Lai, D., Kong, L.H., Shen, M., Yi, F., Liu, B., Wu, F., and Zhou, J.J., Cardiac sodium/calcium exchanger preconditioning promotes anti-arrhythmic and cardioprotective effects through mitochondrial calcium-activated potassium channel, Int. J. Clin. Exp. Pathol., 2015, vol. 8, pp. 10 239–10 249.
Pisarenko, O.I., Ischemic preconditioning: from theory to practice, Kardiol., 2005, no. 9, pp. 62–72.
Ferdinandy, P., Schulz, R., and Baxter, G.F., Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning, Pharmacol. Rev., 2007, vol. 59, pp. 418–458.
Lupanov, V.P. and Maksimenko, A.V., Protective ischemia in cardiology. Myocardial conditioning forms, Kardiovaskul. Ter. Profil., 2011, no. 10, pp. 111–119.
Wang, M., Sun, G.B., Zhang, J.Y., Luo, Y., Yu, Y.L., Xu, X.D., Meng, X.B., Zhang, M.D., Lin, W.B., and Sun, X.B., Elatoside C protects the heart from ischaemia/reperfusion injury through the modulation of oxidative stress and intracellular Ca2+ homeostasis, Int. J. Cardiol., 2015, vol. 185, pp. 167–176.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © I.V. Shemarova, V.P. Nesterov, S.M. Korotkov, K.V. Sobol’, 2017, published in Zhurnal Evolyutsionnoi Biokhimii i Fiziologii, 2017, Vol. 53, No. 5, pp. 328—337.
Rights and permissions
About this article
Cite this article
Shemarova, I.V., Nesterov, V.P., Korotkov, S.M. et al. Involvement of Ca2+ in the development of ischemic disorders of myocardial contractile function. J Evol Biochem Phys 53, 368–379 (2017). https://doi.org/10.1134/S0022093017050027
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0022093017050027